Primary central nervous system lymphoma risk factors: Difference between revisions
No edit summary |
Mahshid |
||
| Line 37: | Line 37: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
[[Category:Hematology]] | |||
Revision as of 15:14, 27 November 2017
|
Primary central nervous system lymphoma Microchapters |
|
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary central nervous system lymphoma risk factors On the Web |
|
American Roentgen Ray Society Images of Primary central nervous system lymphoma risk factors |
|
Primary central nervous system lymphoma risk factors in the news |
|
Blogs on Primary central nervous system lymphoma risk factors |
|
Directions to Hospitals Treating Primary central nervous system lymphoma |
|
Risk calculators and risk factors for Primary central nervous system lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
The most potent risk factor in the development of primary central nervous system lymphoma is a weakened or suppressed immune system in individuals who have acquired immunodeficiency syndrome (AIDS), received an organ transplant and are on immunosuppressants, inherited immunosuppressive disorders (IgA deficiency, Wiskott-Aldrich syndrome, ataxia telangiectasia), and autoimmune disorders (systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis).[1][2][3][4]
Risk Factors
The most potent risk factor in the development of primary central nervous system lymphoma is a weakened or suppressed immune system in individuals who have:[1][2][3][4]
- The highest number of cases occur in individuals with AIDS.
- Received an organ transplant and are on immunosuppressants
- Inherited immunosuppressive disorder
- Autoimmune disorders
References
- ↑ 1.0 1.1 Risks of primary central nervous lymphoma. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/primary-cns-lymphoma/?region=on. Accessed on February 17, 2016
- ↑ 2.0 2.1 Manenti, G.; Di Giuliano, F.; Bindi, A.; Liberto, V.; Funel, V.; Garaci, F. G.; Floris, R.; Simonetti, G. (2013). "A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/916348. ISSN 2090-6862.
- ↑ 3.0 3.1 Epidemiology of primary CNS lymphoma. Dr Amir Rezaee and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/primary-cns-lymphoma. Accessed on February 18, 2016
- ↑ 4.0 4.1 Bhagavathi S, Wilson JD (2008). "Primary central nervous system lymphoma". Arch Pathol Lab Med. 132 (11): 1830–4. doi:10.1043/1543-2165-132.11.1830. PMID 18976024.